Free Trial

GSA Capital Partners LLP Reduces Stock Holdings in Novanta Inc. (NASDAQ:NOVT)

Novanta logo with Computer and Technology background

GSA Capital Partners LLP lessened its stake in shares of Novanta Inc. (NASDAQ:NOVT - Free Report) by 33.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,291 shares of the technology company's stock after selling 2,124 shares during the quarter. GSA Capital Partners LLP's holdings in Novanta were worth $549,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Premier Fund Managers Ltd increased its position in Novanta by 141.2% during the 1st quarter. Premier Fund Managers Ltd now owns 3,053 shares of the technology company's stock worth $394,000 after purchasing an additional 1,787 shares in the last quarter. Norden Group LLC increased its position in Novanta by 6.5% during the 1st quarter. Norden Group LLC now owns 3,079 shares of the technology company's stock worth $394,000 after purchasing an additional 187 shares in the last quarter. Summit Creek Advisors LLC increased its position in Novanta by 21.1% during the 1st quarter. Summit Creek Advisors LLC now owns 56,258 shares of the technology company's stock worth $7,194,000 after purchasing an additional 9,791 shares in the last quarter. TD Asset Management Inc increased its position in Novanta by 5.0% during the 1st quarter. TD Asset Management Inc now owns 23,300 shares of the technology company's stock worth $2,979,000 after purchasing an additional 1,106 shares in the last quarter. Finally, HB Wealth Management LLC purchased a new stake in Novanta during the 1st quarter worth about $239,000. Hedge funds and other institutional investors own 98.35% of the company's stock.

Novanta Stock Up 3.3%

Shares of NASDAQ:NOVT opened at $124.01 on Tuesday. The stock's 50-day moving average price is $126.07 and its two-hundred day moving average price is $130.08. The company has a current ratio of 2.56, a quick ratio of 1.70 and a debt-to-equity ratio of 0.50. Novanta Inc. has a 12-month low of $98.76 and a 12-month high of $186.75. The firm has a market cap of $4.46 billion, a price-to-earnings ratio of 63.27 and a beta of 1.48.

Novanta (NASDAQ:NOVT - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The technology company reported $0.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.68 by $0.06. Novanta had a return on equity of 15.06% and a net margin of 7.42%. The firm had revenue of $233.37 million for the quarter, compared to analyst estimates of $233.34 million. During the same period last year, the company earned $0.74 EPS. The firm's quarterly revenue was up 1.1% on a year-over-year basis. On average, research analysts forecast that Novanta Inc. will post 3.03 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded Novanta from a "hold" rating to a "buy" rating in a research report on Sunday.

Read Our Latest Stock Analysis on Novanta

About Novanta

(Free Report)

Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.

Further Reading

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novanta Right Now?

Before you consider Novanta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.

While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines